CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- Red Sky Partners announced today that Geoffrey (Geoff) Cox, Ph.D., has joined the firm as a Partner. Since its founding in 2009, Red Sky Partners has provided corporate strategy, business development and virtual operating management services to clients in the Biotechnology and Biopharmaceuticals industry.
Geoff brings extensive board, CEO and operating experience to Red Sky. Most recently he served as Chairman and CEO of GTC Therapeutics, and had previously served as Chairman and CEO of Aronex Pharmaceticals. Geoff also previously served as EVP of global operations for Genzyme. He currently serves as Chairman of the Board of MassBio and NABI Therapeutics and as a Director of Gallus BioPharmacetuicals.
"We are delighted to have Geoff join our team," said Tim Surgenor, a founding partner of Red Sky. "His extensive general management and board experience along with his track record of success in developing, partnering and commercializing pioneering biotechnology products will allow us to better serve the needs of our expanding client base."
About Red Sky
Red Sky Partners is a team of seasoned executives who have undertaken numerous assignments for both biopharmaceutical companies and private investors. These engagements have included projects with very specific strategic and transactional objectives, as well as longer-term virtual management roles. As needed, Red Sky leverages a comprehensive network of medical, science and business advisors to provide additional targeted expertise for its clients. www.redskyco.com
Red Sky Partners
Tim Surgenor, 617 584-2638